These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3402574)

  • 1. Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents.
    Glupczynski Y; Delmee M; Bruck C; Labbe M; Avesani V; Burette A
    Eur J Epidemiol; 1988 Jun; 4(2):154-7. PubMed ID: 3402574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.
    Shungu DL; Nalin DR; Gilman RH; Gadebusch HH; Cerami AT; Gill C; Weissberger B
    Antimicrob Agents Chemother; 1987 Jun; 31(6):949-50. PubMed ID: 3619429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
    McNulty CA; Dent J; Wise R
    Antimicrob Agents Chemother; 1985 Dec; 28(6):837-8. PubMed ID: 2935076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
    Andreasen JJ; Andersen LP
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):147-9. PubMed ID: 3591312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.
    Karmali MA; De Grandis S; Fleming PC
    Antimicrob Agents Chemother; 1981 Apr; 19(4):593-7. PubMed ID: 7247381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.
    McNulty CA; Dent JC
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):566-9. PubMed ID: 3141174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
    Simor AE; Ferro S; Low DE
    Antimicrob Agents Chemother; 1989 Jan; 33(1):108-9. PubMed ID: 2712542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics.
    Nagate T; Numata K; Hanada K; Kondo I
    J Clin Gastroenterol; 1990; 12 Suppl 1():S135-8. PubMed ID: 2212539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori).
    Van Caekenberghe DL; Breyssens J
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1429-30. PubMed ID: 3674850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.
    Goodwin CS; Blake P; Blincow E
    J Antimicrob Chemother; 1986 Mar; 17(3):309-14. PubMed ID: 3700291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents.
    Shanker S; Sorrell TC
    Pathology; 1983 Jan; 15(1):61-3. PubMed ID: 6602320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.
    Lariviere LA; Gaudreau CL; Turgeon FF
    J Antimicrob Chemother; 1986 Dec; 18(6):681-5. PubMed ID: 3493235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Denmark to fourteen antimicrobial agents.
    Andreasen JJ
    Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):189-92. PubMed ID: 3630712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents.
    Flores BM; Fennell CL; Holmes KK; Stamm WE
    Antimicrob Agents Chemother; 1985 Aug; 28(2):188-91. PubMed ID: 3834828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.
    Vanhoof R; Gordts B; Dierickx R; Coignau H; Butzler JP
    Antimicrob Agents Chemother; 1980 Jul; 18(1):118-21. PubMed ID: 7416738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of 47 antimicrobial agents against three Campylobacter spp. from pigs.
    Gebhart CJ; Ward GE; Kurtz HJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):55-9. PubMed ID: 3985597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.